Literature DB >> 22349295

A genetic screen to isolate Toxoplasma gondii host-cell egress mutants.

Bradley I Coleman1, Marc-Jan Gubbels.   

Abstract

The widespread, obligate intracellular, protozoan parasite Toxoplasma gondii causes opportunistic disease in immuno-compromised patients and causes birth defects upon congenital infection. The lytic replication cycle is characterized by three stages: 1. active invasion of a nucleated host cell; 2. replication inside the host cell; 3. active egress from the host cell. The mechanism of egress is increasingly being appreciated as a unique, highly regulated process, which is still poorly understood at the molecular level. The signaling pathways underlying egress have been characterized through the use of pharmacological agents acting on different aspects of the pathways. As such, several independent triggers of egress have been identified which all converge on the release of intracellular Ca(2+), a signal that is also critical for host cell invasion. This insight informed a candidate gene approach which led to the identification of plant like calcium dependent protein kinase (CDPK) involved in egress. In addition, several recent breakthroughs in understanding egress have been made using (chemical) genetic approaches. To combine the wealth of pharmacological information with the increasing genetic accessibility of Toxoplasma we recently established a screen permitting the enrichment for parasite mutants with a defect in host cell egress. Although chemical mutagenesis using N-ethyl-N-nitrosourea (ENU) or ethyl methanesulfonate (EMS) has been used for decades in the study of Toxoplasma biology, only recently has genetic mapping of mutations underlying the phenotypes become routine. Furthermore, by generating temperature-sensitive mutants, essential processes can be dissected and the underlying genes directly identified. These mutants behave as wild-type under the permissive temperature (35 °C), but fail to proliferate at the restrictive temperature (40 °C) as a result of the mutation in question. Here we illustrate a new phenotypic screening method to isolate mutants with a temperature-sensitive egress phenotype. The challenge for egress screens is to separate egressed from non-egressed parasites, which is complicated by fast re-invasion and general stickiness of the parasites to host cells. A previously established egress screen was based on a cumbersome series of biotinylation steps to separate intracellular from extracellular parasites. This method also did not generate conditional mutants resulting in weak phenotypes. The method described here overcomes the strong attachment of egressing parasites by including a glycan competitor, dextran sulfate (DS), that prevents parasites from sticking to the host cell. Moreover, extracellular parasites are specifically killed off by pyrrolidine dithiocarbamate (PDTC), which leaves intracellular parasites unharmed. Therefore, with a new phenotypic screen to specifically isolate parasite mutants with defects in induced egress, the power of genetics can now be fully deployed to unravel the molecular mechanisms underlying host cell egress.

Entities:  

Mesh:

Year:  2012        PMID: 22349295      PMCID: PMC3350636          DOI: 10.3791/3807

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  30 in total

1.  Ionophore-resistant mutants of Toxoplasma gondii reveal host cell permeabilization as an early event in egress.

Authors:  M W Black; G Arrizabalaga; J C Boothroyd
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  The loss of cytoplasmic potassium upon host cell breakdown triggers egress of Toxoplasma gondii.

Authors:  R Moudy; T J Manning; C J Beckers
Journal:  J Biol Chem       Date:  2001-08-28       Impact factor: 5.157

3.  High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.

Authors:  Marc-Jan Gubbels; Catherine Li; Boris Striepen
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

4.  A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii.

Authors:  Kimberly L Carey; Nicholas J Westwood; Timothy J Mitchison; Gary E Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

5.  Development of a screen to dissect Toxoplasma gondii egress.

Authors:  Keith P Eidell; Thomas Burke; Marc-Jan Gubbels
Journal:  Mol Biochem Parasitol       Date:  2010-03-21       Impact factor: 1.759

Review 6.  Is Toxoplasma egress the first step in invasion?

Authors:  Eleanor F Hoff; Vern B Carruthers
Journal:  Trends Parasitol       Date:  2002-06

7.  Toxoplasma gondii: selective killing of extracellular parasites by oxidation using pyrrolidine dithiocarbamate.

Authors:  M Camps; J C Boothroyd
Journal:  Exp Parasitol       Date:  2001-08       Impact factor: 2.011

8.  Genetic complementation in apicomplexan parasites.

Authors:  Boris Striepen; Michael W White; Catherine Li; Michael N Guerini; S-Banoo Malik; John M Logsdon; Chang Liu; Mitchell S Abrahamsen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

9.  Toxoplasma gondii microneme secretion involves intracellular Ca(2+) release from inositol 1,4,5-triphosphate (IP(3))/ryanodine-sensitive stores.

Authors:  Jennie L Lovett; Norma Marchesini; Silvia N J Moreno; L David Sibley
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

10.  Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma.

Authors:  Sebastian Lourido; Joel Shuman; Chao Zhang; Kevan M Shokat; Raymond Hui; L David Sibley
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

View more
  12 in total

1.  A forward genetic screen identifies a negative regulator of rapid Ca2+-dependent cell egress (MS1) in the intracellular parasite Toxoplasma gondii.

Authors:  James M McCoy; Rebecca J Stewart; Alessandro D Uboldi; Dongdi Li; Jan Schröder; Nicollas E Scott; Anthony T Papenfuss; Adele M Lehane; Leonard J Foster; Christopher J Tonkin
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

2.  Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.

Authors:  Budhaditya Mukherjee; Francesca Tessaro; Juha Vahokoski; Inari Kursula; Jean-Baptiste Marq; Leonardo Scapozza; Dominique Soldati-Favre
Journal:  EMBO J       Date:  2018-03-08       Impact factor: 11.598

3.  Forward genetics screens using macrophages to identify Toxoplasma gondii genes important for resistance to IFN-γ-dependent cell autonomous immunity.

Authors:  Odaelys Walwyn; Sini Skariah; Brian Lynch; Nathaniel Kim; Yukari Ueda; Neal Vohora; Josh Choe; Dana G Mordue
Journal:  J Vis Exp       Date:  2015-03-12       Impact factor: 1.355

4.  Genetic Evidence for Cytochrome b Qi Site Inhibition by 4(1H)-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondii.

Authors:  P Holland Alday; Igor Bruzual; Aaron Nilsen; Sovitj Pou; Rolf Winter; Choukri Ben Mamoun; Michael K Riscoe; J Stone Doggett
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 5.  Paving the Way: Contributions of Big Data to Apicomplexan and Kinetoplastid Research.

Authors:  Robyn S Kent; Emma M Briggs; Beatrice L Colon; Catalina Alvarez; Sara Silva Pereira; Mariana De Niz
Journal:  Front Cell Infect Microbiol       Date:  2022-06-06       Impact factor: 6.073

6.  Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis.

Authors:  Imaan Benmerzouga; Lisa A Checkley; Michael T Ferdig; Gustavo Arrizabalaga; Ronald C Wek; William J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

7.  Surface attachment, promoted by the actomyosin system of Toxoplasma gondii is important for efficient gliding motility and invasion.

Authors:  Jamie A Whitelaw; Fernanda Latorre-Barragan; Simon Gras; Gurman S Pall; Jacqueline M Leung; Aoife Heaslip; Saskia Egarter; Nicole Andenmatten; Shane R Nelson; David M Warshaw; Gary E Ward; Markus Meissner
Journal:  BMC Biol       Date:  2017-01-18       Impact factor: 7.431

8.  Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis.

Authors:  Andrés Palencia; Alexandre Bougdour; Marie-Pierre Brenier-Pinchart; Bastien Touquet; Rose-Laurence Bertini; Cristina Sensi; Gabrielle Gay; Julien Vollaire; Véronique Josserand; Eric Easom; Yvonne R Freund; Hervé Pelloux; Philip J Rosenthal; Stephen Cusack; Mohamed-Ali Hakimi
Journal:  EMBO Mol Med       Date:  2017-03       Impact factor: 12.137

9.  Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondii.

Authors:  Andrew Farrell; Bradley I Coleman; Brian Benenati; Kevin M Brown; Ira J Blader; Gabor T Marth; Marc-Jan Gubbels
Journal:  BMC Genomics       Date:  2014-05-10       Impact factor: 3.969

10.  A Novel Secreted Protein, MYR1, Is Central to Toxoplasma's Manipulation of Host Cells.

Authors:  Magdalena Franco; Michael W Panas; Nicole D Marino; Mei-Chong Wendy Lee; Kerry R Buchholz; Felice D Kelly; Jeffrey J Bednarski; Barry P Sleckman; Nader Pourmand; John C Boothroyd
Journal:  MBio       Date:  2016-02-02       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.